Skip to main content

Negligence in Prolift Design Cost J&J & Ethicon $35 Million

Negligence in Prolift Design Cost J&J & Ethicon $35 Million

Negligence in Prolift Design Cost J&J & Ethicon $35 Million

Introduction

A nine-person jury panel held J&J and its Ethicon Inc. subsidiary responsible for being negligent in designing and marketing of Prolift, a transvaginal mesh device, which caused chronic pelvic pain since the time the plaintiff underwent a prolapse repair surgery in 2009. The jury pointed that the defendants marketed, sold, and recruited physicians worldwide to implant the mesh implant device for Pelvic Floor Repair in women that suffered from pelvic prolapse. The plaintiff was awarded $10 million as compensatory and $25 million as punitive damages in the U.S. District Court for the Northern District of Indiana Judiciary, with Honorable Judge Philip P. Simon presiding over the 9-day trial.

Over 55,000 product liability claims involving Prolift and other transvaginal mesh implants are a part of the centralized litigation in the U.S. District Court for the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Walgreens Settles Federal Opioid Case for $300 Million

Categories: Opioids

Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.

The U.S. Department of Justice announced on Monday…

Study: Opioid Use in Pregnancy May Shrink Newborn Brains

Categories: Opioids

New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…

Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting

Categories: Opioids

The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…

🛠️ You Have Unfinished Work. We’ll Finish It — Free Trial.            
Free Trial + 25% Off All DLs & Med Review Case Backlog!

Only 12 Firms Can Join – First Come, First Served